BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3492485)

  • 1. In-vitro antibacterial activity of L-105, a new cephalosporin.
    Hikida M; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Nov; 18(5):585-91. PubMed ID: 3492485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.
    Katsu K; Kitoh K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Aug; 22(2):181-5. PubMed ID: 6100421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
    Inoue E; Mitsuhashi S
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1974-9. PubMed ID: 7811005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity and beta-lactamase stability of SK&F 88070 compared with other agents.
    Neu HC; Chin NX; Labthavikul P
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3):223-30. PubMed ID: 3485506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity.
    Fukasawa M; Noguchi H; Okuda T; Komatsu T; Yano K
    Antimicrob Agents Chemother; 1983 Feb; 23(2):195-200. PubMed ID: 6601470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases.
    Fujimoto T; Watanabe M; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1990 Sep; 26(3):329-41. PubMed ID: 2228824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
    Okonogi K; Kuno M; Kida M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological properties of a series of optically active 2-oxaisocephems.
    Tsubouchi H; Ishikawa H
    Bioorg Med Chem; 1995 Feb; 3(2):143-50. PubMed ID: 7796047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
    Mitsukude M; Inoue M; Mitsuhashi S
    Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of BO-1236, a new antipseudomonal cephalosporin.
    Nakagawa S; Sanada M; Matsuda K; Hazumi N; Tanaka N
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1100-5. PubMed ID: 3116919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo antimicrobial activities of a novel cephalosporin derivative, CP6162, possessing a dihydroxypyridone moiety at the C-3 side chain.
    Orikasa Y; Hara T; Miyata A; Tamura A; Kawaharajo K; Matsumoto T; Komiya I; Iwamatsu K; Shibahara S; Inouye S
    J Antimicrob Chemother; 1991 Jan; 27(1):41-53. PubMed ID: 2050596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activities of 2-oxaisocephems.
    Tsubouchi H; Tsuji K; Yasumura K; Ishikawa H
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2084-9. PubMed ID: 7805133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
    Matsui H; Hiraoka M; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Apr; 34(4):555-61. PubMed ID: 2344162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
    Inoue K; Inoue E; Mitsuhashi S
    Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.
    Une T; Otani T; Sato M; Ikeuchi T; Osada Y; Ogawa H; Sato K; Mitsuhashi S
    Antimicrob Agents Chemother; 1985 Apr; 27(4):473-8. PubMed ID: 3873898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cefotaxime against clinically significant pathogens.
    Nakashio S; Nakamura M
    Drugs; 1988; 35 Suppl 2():14-21. PubMed ID: 3260852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity.
    Chabbert YA; Lutz AJ
    Antimicrob Agents Chemother; 1978 Nov; 14(5):749-54. PubMed ID: 31836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.